Light filtering in a retinal pigment epithelial cell culture model

Optometry and Vision Science

Volumn 88, Issue 6, 2011, Pages 759-765

  Zhou, Jilin ^a   Sparrow, Janet R ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

blue light filter; cell viability; Retinal pigment epithelium; RPE

Indexed keywords

ABSORBING DYE; BLUE LIGHT; CELL VIABILITY; FLUORESCENCE LABELING; FLUORESCENT STAINING; INDIANAPOLIS; LIGHT FILTERING; LIGHT LINES; LIGHT PATH; MTT ASSAYS; NON-VIABLE; POLYCARBONATE FILTERS; RETINAL PIGMENT EPITHELIAL; RETINAL PIGMENT EPITHELIAL CELLS; RETINAL PIGMENT EPITHELIUM; RPE; RPE CELL; SHORT WAVELENGTHS; SHORT-WAVELENGTH; STATISTICALLY SIGNIFICANT DIFFERENCE;

ALDEHYDES; ANIMAL CELL CULTURE; BROMINE COMPOUNDS; FLUORESCENCE; IRRADIATION; OPHTHALMOLOGY; TUNGSTEN;

LIGHT;

COLORING AGENT; POLYCARBONATE; POLYCARBOXYLATE CEMENT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ARTICLE; CELL LINE; COLORIMETRY; CYTOLOGY; FILTRATION; HUMAN; LIGHT; PIGMENT EPITHELIUM; RADIATION EXPOSURE; RADIATION INJURY;

CELL LINE; COLORIMETRY; COLORING AGENTS; FILTRATION; HUMANS; LIGHT; POLYCARBOXYLATE CEMENT; RADIATION INJURIES; RETINAL PIGMENT EPITHELIUM; TETRAZOLIUM SALTS; THIAZOLES;

EID: 79958819448     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3182158cdd     Document Type: Article

References (67)

1. Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats. Invest Ophthalmol 1966;5:450-73.
2. Mellerio J. Light effects on the retina. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology: Basic Sciences. Philadelphia, PA: WB Saunders; 1994:1326-45.
3. Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci 1983;24:285-7. (Pubitemid 13108835)
4. Algvere PV, Marshall J, Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand 2006;84:4-15. (Pubitemid 43337467)
5. Ham WT, Jr., Mueller HA, Sliney DH. Retinal sensitivity to damage from short wavelength light. Nature 1976;260:153-5.
6. Grimm C, Wenzel A, Williams T, Rol P, Hafezi F, Reme C. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest Ophthalmol Vis Sci 2001;42:497-505. (Pubitemid 32121486)
7. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res 2005;24:275-306. (Pubitemid 40021788)
8. van Norren D, Schellekens P. Blue light hazard in rat. Vision Res 1990;30:1517-20. (Pubitemid 20278699)
9. Gorgels TG, van Norren D. Ultraviolet and green light cause different types of damage in rat retina. Invest Ophthalmol Vis Sci 1995;36:851-63.
10. Ham WT, Jr., Mueller HA, Ruffolo JJ, Jr., Millen JE, Cleary SF, Guerry RK, Guerry D, III. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 1984;3:165-74. (Pubitemid 14163876)
11. Ham WTJ, Allen RG, Feeney-Burns L, Marmor MF, Parver LM, Proctor PH, et al. The involvement of the retinal pigment epithelium. In: Waxler M, Hitchins VM, eds. CRC Optical Radiation and Visual Health. Boca Raton: CRC Press, Inc 1986;43-67.
12. Friedman E, Kuwabara T. The retinal pigment epithelium. IV. The damaging effects of radiant energy. Arch Ophthalmol 1968;80:265-79.
13. Busch EM, Gorgels TG, Roberts JE, van Norren D. The effects of two stereoisomers of N-acetylcysteine on photochemical damage by UVA and blue light in rat retina. Photochem Photobiol 1999;70:353-8. (Pubitemid 129555885)
14. Ham WT, Jr., Ruffolo JJ, Jr., Mueller HA, Clarke AM, Moon ME. Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light. Invest Ophthalmol Vis Sci 1978;17:1029-35. (Pubitemid 8397576)
15. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 2005;80:595-606. (Pubitemid 40602960)
16. Eldred GE, Lasky MR. Retinal age pigments generated by selfassembling lysosomotropic detergents. Nature 1993;361:724-6. (Pubitemid 23070479)
17. Sakai N, Decatur J, Nakanishi K, Eldred GE. Ocular age pigment "A2E": an unprecedented pyridinium bisretinoid. J Am Chem Soc 1996;118:1559-60.
18. Parish CA, Hashimoto M, Nakanishi K, Dillon J, Sparrow J. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci U S A 1998;95:14609-13. (Pubitemid 29003678)
19. Ben-Shabat S, Parish CA, Vollmer HR, Itagaki Y, Fishkin N, Nakanishi K, Sparrow JR. Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin. J Biol Chem 2002;277:7183-90. (Pubitemid 34953109)
20. Fishkin NE, Sparrow JR, Allikmets R, Nakanishi K. Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc Natl Acad Sci USA 2005;102:7091-6. (Pubitemid 40696339)
21. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2000;41:1981-9. (Pubitemid 30354376)
22. Sparrow JR, Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 2001;42:1356-62. (Pubitemid 32381981)
23. Schutt F, Davies S, Kopitz J, Holz FG, Boulton ME. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 2000;41:2303-8. (Pubitemid 30451007)
24. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 2002;43:1222-7. (Pubitemid 34258296)
25. Ben-Shabat S, Itagaki Y, Jockusch S, Sparrow JR, Turro NJ, Nakanishi K. Formation of a nonaoxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Angew Chem Int Ed Engl 2002;41:814-7. (Pubitemid 34218533)
26. Kim SR, Jang YP, Jockusch S, Fishkin NE, Turro NJ, Sparrow JR. The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc Natl Acad Sci U S A 2007;104:19273-8.
27. Allocca M, Doria M, Petrillo M, Colella P, Garcia-Hoyos M, Gibbs D, Kim SR, Maguire A, Rex TS, Di Vicino U, Cutillo L, Sparrow JR, Williams DS, Bennett J, Auricchio A. Serotypedependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest 2008;118:1955-64. (Pubitemid 351632397)
28. Kong J, Kim SR, Binley K, Pata I, Doi K, Mannik J, Zernant-Rajang J, Kan O, Iqball S, Naylor S, Sparrow JR, Gouras P, Allikmets R. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy. Gene Ther 2008;15:1311-20.
29. Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci U S A 2003;100:4742-7. (Pubitemid 36457800)
30. Radu RA, Han Y, Bui TV, Nusinowitz S, Bok D, Lichter J, Widder K, Travis GH, Mata NL. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci 2005;46:4393-401. (Pubitemid 44264531)
31. Maiti P, Kong J, Kim SR, Sparrow JR, Allikmets R, Rando RR. Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry 2006;45:852-60. (Pubitemid 43122249)
32. Maeda A, Maeda T, Golczak M, Palczewski K. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J Biol Chem 2008;283:26684-93.
33. Sparrow JR, Miller AS, Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg 2004;30:873-8. (Pubitemid 38501484)
34. Sparrow JR. Therapy for macular degeneration: insights from acne. Proc Natl Acad Sci U S A 2003;100:4353-4. (Pubitemid 36457729)
35. Rattner A, Nathans J. Macular degeneration: recent advances and therapeutic opportunities. Nat Rev Neurosci 2006;7:860-72. (Pubitemid 44624178)
36. Sparrow JR, Parish CA, Hashimoto M, Nakanishi K. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 1999;40:2988-95. (Pubitemid 29521615)
37. Dillon J. The photophysics and photobiology of the eye. J Photochem Photobiol B 1991;10:23-40.
38. Leung KW, Barnstable CJ, Tombran-Tink J. Bacterial endotoxin activated retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling. Mol Immunol 2009;46:1374-86.
39. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988;32:252-69. (Pubitemid 18066235)
40. Mainster MA. Light and macular degeneration: a biophysical and clinical perspective. Eye (Lond) 1987;1(Pt. 2):304-10. (Pubitemid 17126434)
41. Taylor HR, West S, Munoz B, Rosenthal FS, Bressler SB, Bressler NM. The long-term effects of visible light on the eye. Arch Ophthalmol 1992;110:99-104.
42. West SK, Rosenthal FS, Bressler NM, Bressler SB, Munoz B, Fine SL, Taylor HR. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989;107:875-9. (Pubitemid 19166363)
43. Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 1993;111:514-8. (Pubitemid 23116899)
44. Cruickshanks KJ, Klein R, Klein BE, Nondahl DM. Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001;119:246-50. (Pubitemid 32147933)
45. Tomany SC, Cruickshanks KJ, Klein R, Klein BE, Knudtson MD. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2004;122:750-7. (Pubitemid 38596256)
46. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000;107:2224-32.
47. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology 1997;104:770-6. (Pubitemid 27200873)
48. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol 1999;117:1384-90. (Pubitemid 30029350)
49. Fletcher AE, Bentham GC, Agnew M, Young IS, Augood C, Chakravarthy U, de Jong PT, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, Vioque J. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol 2008;126:1396-403.
50. Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt's disease-fundus flavimaculatus. Invest Ophthalmol Vis Sci 1995;36:2327-31.
51. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol 2001;119:359-69. (Pubitemid 32207258)
52. Bermann M, Schutt F, Holz FG, Kopitz J. Does A2E, a retinoid component of lipofuscin and inhibitor of lysosomal degradative functions, directly affect the activity of lysosomal hydrolases? Exp Eye Res 2001;72:191-5. (Pubitemid 32976983)
53. Eldred GE. Lipofuscin fluorophore inhibits lysosomal protein degradation and may cause early stages of macular degeneration. Gerontology 1995;41(suppl. 2):15-28. (Pubitemid 26019903)
54. Liu J, Lu W, Reigada D, Nguyen J, Laties AM, Mitchell CH. Restoration of lysosomal pH in RPE cells from cultured human and ABCA4 (-/-) mice: pharmacologic approaches and functional recovery. Invest Ophthalmol Vis Sci 2008;49:772-80.
55. Sparrow JR, Cai B, Jang YP, Zhou J, Nakanishi K. A2E, a fluorophore of RPE lipofuscin, can destabilize membrane. Adv Exp Med Biol 2006;572:63-8. (Pubitemid 44249754)
56. Sparrow JR, Fishkin N, Zhou J, Cai B, Jang YP, Krane S, Itagaki Y, Nakanishi K. A2E, a byproduct of the visual cycle. Vision Res 2003;43:2983-90. (Pubitemid 37377610)
57. Chylack LT. Aging changes in the crystalline lens and zonules. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology: Basic Sciences. Philadelphia, PA: WB Saunders; 1994:702-10.
58. Gaillard ER, Zheng L, Merriam JC, Dillon J. Age-related changes in the absorption characteristics of the primate lens. Invest Ophthalmol Vis Sci 2000;41:1454-9. (Pubitemid 30261869)
59. Mellerio J. Yellowing of the human lens: nuclear and cortical contributions. Vision Res 1987;27:1581-7. (Pubitemid 17145834)
60. Weale RA. Human lenticular fluorescence and transmissivity, and their effects on vision. Exp Eye Res 1985;41:457-73. (Pubitemid 16206253)
61. Weale RA. Age and the transmittance of the human crystalline lens. J Physiol 1988;395:577-87. (Pubitemid 18029213)
62. Zhou J, Jang YP, Kim SR, Sparrow JR. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci U S A 2006;103:16182-7. (Pubitemid 44715171)
63. Zhou J, Kim SR, Westlund BS, Sparrow JR. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci 2009;50:1392-9.
64. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-4. (Pubitemid 40530082)
65. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005;102:7227-32. (Pubitemid 40696361)
66. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21. (Pubitemid 40530081)
67. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9. (Pubitemid 40530070)